Gilead’s HIV Patent Spat With HHS Could Keep Drug Prices High
November 25, 2019
Valerie Bauman
Bloomberg Law
Axinn partner Chad Landmon was quoted in the Bloomberg Law article, "Gilead’s HIV Patent Spat With HHS Could Keep Drug Prices High."
Click here to access the article.